JP2011507880A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011507880A5 JP2011507880A5 JP2010539775A JP2010539775A JP2011507880A5 JP 2011507880 A5 JP2011507880 A5 JP 2011507880A5 JP 2010539775 A JP2010539775 A JP 2010539775A JP 2010539775 A JP2010539775 A JP 2010539775A JP 2011507880 A5 JP2011507880 A5 JP 2011507880A5
- Authority
- JP
- Japan
- Prior art keywords
- patients
- years
- treated
- chlorambucil
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- JCKYGMPEJWAADB-UHFFFAOYSA-N chlorambucil Chemical compound OC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 JCKYGMPEJWAADB-UHFFFAOYSA-N 0.000 description 2
- 229960004630 chlorambucil Drugs 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 1
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000012956 testing procedure Methods 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1570407P | 2007-12-21 | 2007-12-21 | |
| PCT/US2008/087336 WO2009082662A1 (en) | 2007-12-21 | 2008-12-18 | Combination of nilotinib and a nitrogen mustard analogue for the treatment of chronic lymphocytic leukemia |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014115061A Division JP2014177487A (ja) | 2007-12-21 | 2014-06-03 | 慢性リンパ性白血病の処置のためのニロチニブとナイトロジェンマスタードの組み合わせ剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011507880A JP2011507880A (ja) | 2011-03-10 |
| JP2011507880A5 true JP2011507880A5 (cg-RX-API-DMAC7.html) | 2012-01-26 |
Family
ID=40352369
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010539775A Pending JP2011507880A (ja) | 2007-12-21 | 2008-12-18 | 慢性リンパ性白血病の処置のためのニロチニブとナイトロジェンマスタードの組み合わせ剤 |
| JP2014115061A Pending JP2014177487A (ja) | 2007-12-21 | 2014-06-03 | 慢性リンパ性白血病の処置のためのニロチニブとナイトロジェンマスタードの組み合わせ剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014115061A Pending JP2014177487A (ja) | 2007-12-21 | 2014-06-03 | 慢性リンパ性白血病の処置のためのニロチニブとナイトロジェンマスタードの組み合わせ剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20110028422A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2240172B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2011507880A (cg-RX-API-DMAC7.html) |
| ES (1) | ES2459877T3 (cg-RX-API-DMAC7.html) |
| PL (1) | PL2240172T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT2240172E (cg-RX-API-DMAC7.html) |
| WO (1) | WO2009082662A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2425830A1 (en) * | 2010-09-03 | 2012-03-07 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Synergistic drug combination for the treatment of cancer |
| US20150182490A1 (en) | 2012-06-26 | 2015-07-02 | Del Mar Pharmaceuticals | Methods for treating tyrosine-kinase-inhibitor-resistant malignancies in patients with genetic polymorphisms or ahi1 dysregulations or mutations employing dianhydrogalactitol, diacetyldianhydrogalactitol, dibromodulcitol, or analogs or derivatives thereof |
| CN105492011A (zh) | 2013-04-08 | 2016-04-13 | 丹尼斯·M·布朗 | 不理想给药化学化合物的治疗增效 |
| CA2941632C (en) * | 2014-03-13 | 2023-10-24 | Vasilios VOUDOURIS | Bendamustine solid dispersions and continuous infusion |
| US9777572B2 (en) * | 2014-11-17 | 2017-10-03 | Baker Hughes Incorporated | Multi-probe reservoir sampling device |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3046301A (en) | 1959-10-29 | 1962-07-24 | Burroughs Wellcome Co | Method of making chlorambucil |
| GB0215676D0 (en) | 2002-07-05 | 2002-08-14 | Novartis Ag | Organic compounds |
| ATE468855T1 (de) | 2002-11-12 | 2010-06-15 | Jewish General Hospital | Kombination von stickstoff-senf analogen und imatinib für die behandlung von chronischer lymphatischer leukämie |
| GT200600315A (es) | 2005-07-20 | 2007-03-19 | Formas cristalinas de 4-metilo-n-[3-(4-metilo-imidazol-1-ilo)-5-trifluorometilo-fenilo]-3-(4-pyridina-3-ilo-pirimidina-2-iloamino)-benzamida |
-
2008
- 2008-12-18 EP EP08864891.0A patent/EP2240172B1/en not_active Not-in-force
- 2008-12-18 JP JP2010539775A patent/JP2011507880A/ja active Pending
- 2008-12-18 PT PT88648910T patent/PT2240172E/pt unknown
- 2008-12-18 US US12/809,805 patent/US20110028422A1/en not_active Abandoned
- 2008-12-18 WO PCT/US2008/087336 patent/WO2009082662A1/en not_active Ceased
- 2008-12-18 ES ES08864891.0T patent/ES2459877T3/es active Active
- 2008-12-18 PL PL08864891T patent/PL2240172T3/pl unknown
-
2014
- 2014-06-03 JP JP2014115061A patent/JP2014177487A/ja active Pending
- 2014-10-27 US US14/524,493 patent/US20150051236A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Esquirol et al. | Shift work and cardiovascular risk factors: new knowledge from the past decade | |
| PH12012502226A1 (en) | Il-1 binding proteins | |
| CA2863393A1 (en) | A multi-biomarker-based outcome risk stratification model for pediatric septic shock | |
| WO2008042231A3 (en) | Compositions and methods for evaluating and treating heart failure | |
| WO2009137807A3 (en) | Compositions and methods related to mirna modulation of neovascularization or angiogenesis | |
| WO2009152484A3 (en) | Methods and platforms for drug discovery | |
| EA200801046A1 (ru) | Неинвазивный способ выявления переходно-клеточной карциномы мочевого пузыря in vitro | |
| WO2007061906A3 (en) | Diagnostic and therapeutics for cardiovascular disorders | |
| Bobińska et al. | The role of MMP genes in recurrent depressive disorders and cognitive functions | |
| EP2532748A3 (en) | DNA aptamer specifically binding to human cardiac troponin I | |
| WO2008033427A3 (en) | Compositions and methods for detection of lysosomal storage disease | |
| WO2010004283A3 (en) | Sulfonylurea receptor and means for treating ischaemia | |
| FI20115670A0 (fi) | Kardiovaskulaarinen in vitro-malli | |
| WO2011133036A3 (en) | Means and methods for determining risk of cardiovascular disease | |
| JP2012506031A5 (cg-RX-API-DMAC7.html) | ||
| WO2013066879A3 (en) | SOLUBLE UROKINASE RECEPTOR (suPAR) IN DIABETIC KIDNEY DISEASE | |
| Leone | Patterns and composition of weight change in college freshmen | |
| WO2014117680A3 (zh) | 外周血细胞TRPC6mRNA水平用于早期预测/诊断老年性痴呆 | |
| Wu et al. | Nuclear Translocation of β‐Catenin Mediates the Parathyroid Hormone‐Induced Endothelial‐to‐Mesenchymal Transition in Human Renal Glomerular Endothelial Cells | |
| Bose et al. | P. 2. e. 016 Cariprazine in the treatment of acute mania in bipolar disorder: a double-blind, placebo-controlled, phase III trial | |
| ATE523602T1 (de) | Mit durch antipsychotika induzierten extrapyramidalen symptomen assoziierte rgs2- genotypen | |
| Shavva et al. | Proliferation of activated hepatic stellate cells requires REST | |
| JP2010502179A5 (cg-RX-API-DMAC7.html) | ||
| EP1773762A4 (en) | METHODS AND COMPOUNDS FOR DETECTING MEDICAL DISORDERS | |
| AR080471A1 (es) | Participacion de la via de androgenos/receptores de androgenos en la enfermedad de fabry |